Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus

Explore clinical trials studying Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

6,409 public trials 526 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus trial results

Completed

Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes

NCT00604396

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Arlon, Belgium
  • Novo Nordisk Investigational Site Gilly, Belgium
  • Novo Nordisk Investigational Site Huy, Belgium
  • Novo Nordisk Investigational Site Jumet, Belgium
View all 62 locations
View Trial Details
Completed

Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes

NCT00312104

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Graz, Austria
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Vienna, Austria
View all 46 locations
View Trial Details
Completed

Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes

NCT00097084

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Little Rock, Arkansas, United States
  • Novo Nordisk Investigational Site Inglewood, California, United States
  • Novo Nordisk Investigational Site San Francisco, California, United States
  • Novo Nordisk Investigational Site Santa Ana, California, United States
View all 60 locations
View Trial Details
Completed

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

NCT00095082

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site Huntington Beach, California, United States
  • Novo Nordisk Investigational Site Inglewood, California, United States
  • Novo Nordisk Investigational Site Irvine, California, United States
View all 81 locations
View Trial Details
Completed

Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes

NCT00283751

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Greenbrae, California, United States
  • Novo Nordisk Investigational Site La Mesa, California, United States
  • Novo Nordisk Investigational Site West Palm Beach, Florida, United States
  • Novo Nordisk Investigational Site Atlanta, Georgia, United States
View all 96 locations
View Trial Details
Completed

Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes

NCT01697657

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Camperdown, New South Wales, Australia
  • Novo Nordisk Investigational Site Ashford, Australia
  • Novo Nordisk Investigational Site Box Hill, Australia
  • Novo Nordisk Investigational Site Zagreb, Croatia
View Trial Details
Completed

A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker

NCT01137474

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Horizon Research Group, Inc. Mobile, Alabama, United States
  • Iicr, Inc. (International Institute Of Clinical Research) Ozark, Alabama, United States
  • Hope Research Institute Phoenix, Arizona, United States
View all 329 locations
View Trial Details
Completed

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00331851

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Bahía Blanca, Argentina
  • Novo Nordisk Investigational Site Ciudad Autonoma de Bs As, Argentina
  • Novo Nordisk Investigational Site Junín, Argentina
  • Novo Nordisk Investigational Site Mendoza, Argentina
View all 116 locations
View Trial Details

Related conditions